In patients with aggressive ATLL, most leukemic cells were CD39+, while the ratios of CD39 expressing leukemic cells in chronic/smoldering patients or in asymptomatic carriers are significantly lower than in patients with aggressive type (Fig. 2d). The gene discussed is ENTPD1; the disease is adult T-cell leukemia/lymphoma.